Hospira Recalls Lidocaine Hydrochloride Injection Due to Particulate Matter
Hospira, Inc. is recalling 1% Lidocaine Hydrochloride Injection vials because oxidized stainless steel was found in the product.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 5 according to the rubric.
Plain-English summary
Hospira, Inc. is recalling 374,500 vials of 1% Lidocaine Hydrochloride Injection, USP (NDC 0409-4276-01). The recall was initiated due to the presence of particulate matter, specifically oxidized stainless steel, found in a vial of the product.
The affected product is identified by Lot #25090DK and has an expiration date of 01/15. The vials were distributed nationwide. The product is a human prescription drug intended for infiltration and perineural routes.
Consumers and healthcare providers should stop using the affected vials and contact their supplier or Hospira, Inc. for further instructions or a return.
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Hospira, Inc.
- Category
- Drug — Injection
- Affected units
- 374,500
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #25090DK
- Exp 01/15
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- HighSpectra lidocaine ampules recalled over lack of sterility assurance
FDA (Drugs) · 2026-06-10
- HighHuons lidocaine injection recalled nationwide over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- HighHuons lidocaine 2% injection recalled over lack of sterility assurance
FDA (Drugs) · 2026-04-22
- SeverePfizer Lidocaine Injection Recall: Glass Particulates in Injectable Medication
FDA (Drugs) · 2023-11-15
Same manufacturer · Hospira, Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26